Calcium antagonists in clinical practice: focus on metabolic and vascular effects

被引:0
|
作者
Nebieridze, D. V. [1 ]
机构
[1] State Res Ctr Prevent Med Roszdrav, Moscow, Russia
关键词
calcium antagonists; diltiazem; endothelium dysfunction;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficacy of calcium antagonists widely used in cardiological practice is proved both by placebo-controlled studies and in comparative trials with end-point control. Calcium antagonists are the most effective vasoprotective medicines. In our study we had shown antihypertensive efficacy and ability to improve endotheliumfunction of non-dihydropyridine calcium antagonist, diltiazem(AltiazemRR). AltiazemRR can be drug of choice in wide profile of patients with arterial hypertension, especially in those with concomitant metabolic abnormalities, diabetes mellitus and ischemic heart disease.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 50 条
  • [21] The coronary selectivity of calcium antagonists - Focus on CHD
    Godfraind, T
    NISOLDIPINE COAT-CORE, 1999, : 1 - 13
  • [23] ANTIATHEROSCLEROTIC AND VASCULOPROTECTIVE EFFECTS OF CALCIUM-ANTAGONISTS - CLINICAL IMPLICATIONS
    VENKATA, C
    RAM, S
    JOURNAL OF HUMAN HYPERTENSION, 1990, 4 : 35 - 39
  • [24] New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects
    Dragomiretskaya, Natalia A.
    Tarzimanova, Aida, I
    Kucherova, Julia S.
    Podzolkov, Valery, I
    TERAPEVTICHESKII ARKHIV, 2021, 93 (09) : 1132 - 1137
  • [25] Vascular and metabolic effects of treatment of combined hyperlipidemia: Focus on statins and fibrates
    Koh, Kwang Kon
    Quon, Michael J.
    Rosenson, Robert S.
    Chung, Wook-Jin
    Han, Seung Hwan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 124 (02) : 149 - 159
  • [26] Clinical pharmacokinetics of the calcium antagonists
    Sesin, J
    Tamargo, J
    MEDICINA-BUENOS AIRES, 1997, 57 (04) : 451 - 462
  • [27] Vascular protective effects of dihydropyridine calcium antagonists -: Involvement of endothelial nitric oxide
    Berkels, R
    Taubert, D
    Rosenkranz, A
    Rösen, R
    PHARMACOLOGY, 2003, 69 (04) : 171 - 176
  • [28] HEMODYNAMIC-EFFECTS OF CALCIUM-ANTAGONISTS WITH HIGH OR LOW VASCULAR SELECTIVITY
    THOREN, P
    SJOLANDER, M
    NORDLANDER, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S21 - S24
  • [29] VASCULAR ANGIOTENSIN BLOCKADE BY CALCIUM-ANTAGONISTS
    ANDRAWIS, NS
    CRAFT, N
    ABERNETHY, DR
    FASEB JOURNAL, 1991, 5 (04): : A841 - A841
  • [30] VASCULAR IMPACT OF DIHYDROPYRIDINES CALCIUM-ANTAGONISTS
    LIBERSA, C
    BORDET, R
    CARON, J
    GUEDONMOREAU, L
    THERAPIE, 1995, 50 (02): : 101 - 108